Cargando…

Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

INTRODUCTION: This study describes the frequency of prescription claims for drugs that may interact with Janus kinase (JAK) inhibitors among adult patients with rheumatoid arthritis (RA) in a large US claims database. METHODS: This observational, retrospective, cross-sectional study of the IBM(®) Ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walton, Alison, Paik, Jim, Quebe, Amanda, Kannowski, Carol L., Choong, Casey, Anderson, Seth, Owensby, Justin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991043/ https://www.ncbi.nlm.nih.gov/pubmed/33484433 http://dx.doi.org/10.1007/s40744-020-00275-8

Ejemplares similares

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
por: Giles, Jon T., et al.
Publicado: (2021)

Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study
por: Nowell, William Benjamin, et al.
Publicado: (2019)

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2021)

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis
por: Katz, Patricia, et al.
Publicado: (2020)

Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials
por: McGuiness, Catherine B., et al.
Publicado: (2021)

SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US
por: Ezendu, Kyrian, et al.
Publicado: (2023)

Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data
por: Choong, Casey K., et al.
Publicado: (2018)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data
por: Choong, Casey K., et al.
Publicado: (2017)

Association Between Opioid Prescriptions and Non–US-Born Status in the US
por: Wilson, Fernando A., et al.
Publicado: (2020)

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
por: Ni, Han, et al.
Publicado: (2013)

Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims
por: Fenske, Christian, et al.
Publicado: (2022)

Frequency Response of Induced-Charge Electrophoretic Metallic Janus Particles
por: Shen, Chong, et al.
Publicado: (2020)

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data
por: Dahlgren, F. Scott, et al.
Publicado: (2018)

Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data
por: Shridharmurthy, Divya, et al.
Publicado: (2022)

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database
por: Baer, Philip A, et al.
Publicado: (2018)

K-means clustering of outpatient prescription claims for health insureds in Iran
por: Momahhed, Shekoofeh Sadat, et al.
Publicado: (2023)

Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
por: Petri, Hans, et al.
Publicado: (2010)

Frequency of Medical Claims for Diastasis Recti Abdominis Among U.S. Active Duty Service Women, 2016 to 2019
por: Korona-Bailey, Jessica, et al.
Publicado: (2023)

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database [Erratum]
Publicado: (2018)

The U.S. Labor Relations System after Janus v. AFSCME: an Early Assessment
por: Hodges, Ann C.
Publicado: (2021)

Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
por: Milici, Anthony J, et al.
Publicado: (2008)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
por: Kotyla, Przemysław J., et al.
Publicado: (2020)

Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors
por: Koh, Jung Hee, et al.
Publicado: (2023)

Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib
por: Harrington, Robert, et al.
Publicado: (2023)

Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2023)

Prescription fill rates for acute and chronic medications in claims-EMR linked data
por: Park, Yoonyoung, et al.
Publicado: (2018)

Quantification of missing prescriptions in commercial claims databases: results of a cohort study
por: Cepeda, Maria Soledad, et al.
Publicado: (2017)

Prescription of analgesics in patients with rheumatic diseases in Germany: A claims data analysis
por: Albrecht, K., et al.
Publicado: (2021)

Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database
por: Zedler, Barbara K, et al.
Publicado: (2018)

Amphiphilic Janus Particles Confined in Symmetrical and Janus-Like Slits
por: Baran, Łukasz, et al.
Publicado: (2023)

Novel Potential Janus Kinase Inhibitors with Therapeutic Prospects in Rheumatoid Arthritis Addressed by In Silico Studies
por: Radu, Andrei-Flavius, et al.
Publicado: (2023)

Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2023)

Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia
por: Temmoku, Jumpei, et al.
Publicado: (2023)

Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan
por: Otaki, Yasuhiro, et al.
Publicado: (2017)

Empire of law and indian justice in colonial Mexico /
por: Owensby, Brian Philip, 1959-
Publicado: (2008)

Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012
por: Ailes, Elizabeth C., et al.
Publicado: (2015)

Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea
por: Jung, Minji, et al.
Publicado: (2020)

Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data
por: Scholle, Oliver, et al.
Publicado: (2021)

Prescription smoking-cessation medication pharmacy claims after stroke and transient ischemic attack
por: Parikh, Neal S., et al.
Publicado: (2021)

Opiate Prescriptions Vary among Common Urologic Procedures: A Claims Dataset Analysis
por: Patel, Anish B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4jp0f2g6mm3lv7qann2cu5fmf